Entyvio 108 MG/0.68 ML pen 0.68ML
Ended Awarded
- Contract number
- SPE2DR26F9BN5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,956
Award facts
- Contract value 100% obligated
- $12,956.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Entyvio 108 mg/0.68 mL pen injectors with a ceiling value of $12,956.10 under firm fixed price terms. The contract, which is not set-aside, has an ultimate completion date of December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement through December 2026 that enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company has demonstrated its capability to meet federal requirements through competitive awards, as evidenced by its extensive portfolio of delivery orders for brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The current award for Entyvio—a specialty medication used in the treatment of inflammatory bowel disease—reflects the company's role in supplying specialized pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9BN5?
SPE2DR26F9BN5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9BN5 worth?
The government has obligated $12,956 on SPE2DR26F9BN5.
Is contract SPE2DR26F9BN5 an order under another contract?
Yes. SPE2DR26F9BN5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9BN5 competed?
The extent of competition for SPE2DR26F9BN5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award